EDGARDO A OSEA

Allopathic & Osteopathic Physicians|Internal Medicine CARSON, CA NPI 1699795476

General Payments — all program years on this page

$2,202.57

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $387.32 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $387.3213

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $232.415
Janssen Pharmaceuticals, Inc $57.963
Novo Nordisk AS $39.872
Abbott Laboratories $28.401
DEXCOM, INC. $14.421
Janssen Biotech, Inc. $14.261

By program year

Program yearAmountRecords
2018 $155.193
2019 $204.617
2020 $183.7310
2021 $328.0516
2022 $421.1319
2023 $522.5412
2024 $387.3213

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077920269 Janssen Pharmaceuticals, Inc $23.38 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077920271 Janssen Pharmaceuticals, Inc $13.73 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077920281 Janssen Pharmaceuticals, Inc $20.85 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078290069 Janssen Biotech, Inc. $14.26 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097386927 Novo Nordisk Inc $21.40 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097621553 Novo Nordisk Inc $18.47 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104244753 AstraZeneca Pharmaceuticals LP $34.70 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105461984 AstraZeneca Pharmaceuticals LP $30.41 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105494357 AstraZeneca Pharmaceuticals LP $27.08 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105526181 AstraZeneca Pharmaceuticals LP $88.13 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105579832 AstraZeneca Pharmaceuticals LP $52.09 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125204866 Abbott Laboratories $28.40 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153297492 Dexcom, Inc. $14.42 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.